Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
The Epstein-Barr virus (EBV) infects more than 95% of adults worldwide and is associated with various malignant tumors and immune diseases, imparting a huge disease burden on the human population. Available EBV vaccines are imminent. Prophylactic vaccines can effectively prevent the spread of infect...
Guardado en:
Autores principales: | Jing Cai, Bodou Zhang, Yuqi Li, Wanfang Zhu, Toshihiro Akihisa, Wei Li, Takashi Kikuchi, Wenyuan Liu, Feng Feng, Jie Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/78145038ac81461b8b5a4ba35877c8c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EPSTEIN–BARR VIRUS IN THE POPULATION OF TWO GEOGRAPHICALLY DIFFERENT REGIONS OF RUSSIA
por: N. B. Senyuta, et al.
Publicado: (2017) -
Epigenetic Regulation of Tumor Suppressors by <italic toggle="yes">Helicobacter pylori</italic> Enhances EBV-Induced Proliferation of Gastric Epithelial Cells
por: Saurabh Pandey, et al.
Publicado: (2018) -
Convulsiones y paro cardiaco: forma inhabitual de presentación de miocarditis asociada a virus de Epstein Barr
por: Mericq G,Verónica, et al.
Publicado: (1993) -
Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
por: Qian-Ying Zhu, et al.
Publicado: (2020) -
Associação do vírus Epstein-Barr (EBV) com tumores sólidos
por: Marcos Antonio Pereira de Lima, et al.
Publicado: (2006)